Eupraxia Pharmaceuticals Stock Quote EPRX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.01

Bid

3.24

Ask

4.18

Volume

660

3.01 Day's Range 3.05

2.20 52 Week Range 4.08

Market Cap

107.224M

Previous Close

3.08

Open

3.05

Last Trade

3.21

Last Trade Time

17:29:46

Financial Volume

$ 2,000

VWAP

3.03

Average Volume (3m)

17,314

Shares Outstanding

35,622,553

Dividend Yield

PE Ratio

-5.53

Earnings Per Share (EPS)

-0.79

Revenue

Net Profit

-28.22M

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eupraxiapharma.com

Headquarters

Victoria, British Columbia, Can

Founded

Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $3.08. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 2.20 to $ 4.08.

Eupraxia Pharmaceuticals currently has 35,622,553 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $109.72 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.53.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Nov. 12, 2024...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	0.333333333333	3	3.08	2.84	11108	3.06860143	CS
4	-0.111	-3.55655238706	3.121	3.23	2.75	6686	3.08208657	CS
12	0.55	22.3577235772	2.46	4.08	2.326	17314	3.27832656	CS
26	0.35	13.1578947368	2.66	4.08	2.2	11766	3.04181598	CS
52	-0.54	-15.2112676056	3.55	4.08	2.2	15378	2.93895602	CS
156	-0.54	-15.2112676056	3.55	4.08	2.2	15378	2.93895602	CS
260	-0.54	-15.2112676056	3.55	4.08	2.2	15378	2.93895602	CS

EPRX - Frequently Asked Questions (FAQ)

What is the current Eupraxia Pharmaceuticals share price?

The current share price of Eupraxia Pharmaceuticals is $ 3.01

How many Eupraxia Pharmaceuticals shares are in issue?

Eupraxia Pharmaceuticals has 35,622,553 shares in issue

What is the market cap of Eupraxia Pharmaceuticals?

The market capitalisation of Eupraxia Pharmaceuticals is USD 109.72M

What is the 1 year trading range for Eupraxia Pharmaceuticals share price?

Eupraxia Pharmaceuticals has traded in the range of $ 2.20 to $ 4.08 during the past year

What is the PE ratio of Eupraxia Pharmaceuticals?

The price to earnings ratio of Eupraxia Pharmaceuticals is -5.53

What is the reporting currency for Eupraxia Pharmaceuticals?

Eupraxia Pharmaceuticals reports financial results in USD

What is the latest annual profit for Eupraxia Pharmaceuticals?

The latest annual profit of Eupraxia Pharmaceuticals is USD -28.22M

What is the registered address of Eupraxia Pharmaceuticals?

The registered address for Eupraxia Pharmaceuticals is 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.

What is the Eupraxia Pharmaceuticals website address?

The website address for Eupraxia Pharmaceuticals is www.eupraxiapharma.com

Which industry sector does Eupraxia Pharmaceuticals operate in?

Eupraxia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JSPRWJasper Therapeutics Inc	$ 0.30 (100.00%)	100
NUKKNukkleus Inc	$ 28.7388 (39.98%)	1.36M
VSVersus Systems Inc	$ 2.64 (37.50%)	2.78M
TGLTreasure Global Inc	$ 0.2563 (19.60%)	3.33M
ISPCiSpecimen Inc	$ 3.38 (18.60%)	2.77M
RIMEAlgorhythm Holdings Inc	$ 0.0355 (-16.08%)	29.49M
QTIQT Imaging Holdings Inc	$ 0.449 (-14.67%)	63.11k
RFILRF Industries Ltd	$ 4.0613 (-10.94%)	11.63k
LTRNLantern Pharma Inc	$ 3.2501 (-9.72%)	160
ORKTOrangeKloud Technology Inc	$ 3.63 (-9.70%)	89.07k
RIMEAlgorhythm Holdings Inc	$ 0.0355 (-16.08%)	29.49M
ENVBEnveric Biosciences Inc	$ 0.3837 (9.60%)	7.53M
ACONAclarion Inc	$ 0.0459 (2.00%)	5.33M
TGLTreasure Global Inc	$ 0.2563 (19.60%)	3.33M
PLUGPlug Power Inc	$ 2.84 (3.65%)	3.32M